Search clinical trials for: Open-Label Study

Total 119262 results

Janssen Korea, Ltd., Korea

Completed

An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients

Pain
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

Extension Study of Talampanel for Amyotrophic Lateral Sclerosis (ALS) (ALSTAR OL)

Amyotrophic Lateral Sclerosis
Duramed Research

Completed

Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive

Contraception

United States
Kenneth Peters, MD
Celgene Corporation; William Beaumont Hospitals

Terminated

Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain

Pelvic Pain | Chronic Prostatitis

United States
West China Hospital

Completed

A Dose-response Study of Lidocaine and Etomidate

Etomidate Overdose of Undetermined Intent
The Medical Research Network
Pfizer; Liebowitz, Michael R., M.D.

Completed

Open-Label Study of Geodon in Non-Rapid Cycling Bipolar II Patients With Major Depression

Major Depressive Episode | Bipolar II Disorder

United States
Seaside Therapeutics, Inc.

Completed

Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders

Autism Spectrum Disorders

United States
Massachusetts General Hospital

Completed

Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

Bipolar Spectrum Disorder
Eisai Inc.

Completed

Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations

Insomnia

United States
M.D. Anderson Cancer Center
Cortice Biosciences, Inc.

Withdrawn

Open-Label Study of TPI 287 for Patients With Metastatic Melanoma

Metastatic Melanoma

United States
AIO-Studien-gGmbH
iOMEDICO AG

Terminated

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer (VOXEL)

Colorectal Neoplasms

Germany
Massachusetts General Hospital
National Center for Complementary and Integrative Health (NCCIH); Harvard University

Completed

Pilot Study of Open-label Placebo to Treat Major Depressive Disorder

Major Depressive Disorder

United States
AbbVie (prior sponsor, Abbott)

Completed

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

Diabetic Neuropathic Pain

United Kingdom
RenaMed Biologics

Completed

Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure

Acute Renal Failure

United States
Merz Pharmaceuticals GmbH

Terminated

Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus (OLLTT)

Subjective Tinnitus

United States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
Cephalon

Terminated

Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain

Pain | Chronic Pain | Breakthrough Pain

United States
Valneva Austria GmbH
PATH

Completed

Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47

Pneumococcal Infections

Germany
ZARS Pharma Inc.

Completed

Pharmacokinetic Study of Synera in Healthy Volunteers

Healthy

United States
Kythera Biopharmaceuticals

Completed

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

Healthy

United States
VIVUS LLC
Synteract, Inc.; Sentrx

Terminated

Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic Adults

Diabetes

United States
Tibotec BVBA

Completed

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

HIV | Tuberculosis
Pfizer

Completed

Post Marketing Surveillance Study on Linezolid (A5951090)

Gram-Positive Bacterial Infections
Threshold Pharmaceuticals

Completed

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors

Hypoxia | Tumors

United States
Cephalon

Completed

Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer

Cancer
Millennium Pharmaceuticals, Inc.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Open-Label Phase 1/2 Study of VELCADE for Injection in Patients With Light-chain (AL)-Amyloidosis

Amyloidosis

United States
Gilead Sciences

Completed

Open-Label Hepatic Impairment Study

Hepatitis C

United States, Puerto Rico
Massachusetts General Hospital

Completed

Open-Label Pilot Study of Namenda in Adult Subjects With ADHD and ADHD NOS

ADHD

United States
Novartis Pharmaceuticals

Completed

Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

Iron Overload

Spain
Pfizer

Terminated

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension (STRIDE-3)

Pulmonary Arterial Hypertension

United States, Netherlands, Canada, Belgium, France, Germany, Italy, Spain, United Kingdom, Australia, Poland, Austria, Brazil, Israel, Argentina, Mexico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program

Depressive Disorder, Major

United States
ZARS Pharma Inc.

Completed

Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome

Shoulder Impingement Syndrome

United States
ZARS Pharma Inc.

Completed

Study Evaluating Heated Lidocaine/Tetracaine Patch in Patients With Pain Associated With Myofascial Trigger Points

Myofascial Pain Syndromes

United States
ZARS Pharma Inc.

Completed

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

United States
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis

Multiple Sclerosis

United States, Canada
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial

Multiple Sclerosis

United States, Canada
Acorda Therapeutics

Completed

Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR Tablets in Multiple Sclerosis Patients Who Participated in the MS-F203 Trial

Multiple Sclerosis

United States, Canada
AstraZeneca

Completed

A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg (Plus 250mg Loading Regimen) and 500mg (FINDER I)

Advanced Breast Cancer | Metastatic Breast Cancer

Japan
Eli Lilly and Company

Completed

Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Schizoaffective Disorder | Schizophrenic Disorders

United States, France, Italy, Belgium, Mexico, Russian Federation, Puerto Rico, Taiwan, Australia, Romania, Croatia, Germany, Poland, Spain, Argentina, Brazil, Portugal, Slovakia, South Africa, Israel, Hungary, Austria, Czech Republic, Netherlan... and more
Savient Pharmaceuticals

Completed

Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout

Gout

United States
William Beaumont Hospitals

Completed

Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy

Prostate Cancer

United States
Pfizer

Completed

Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects

Pharmacokinetics

United States
Eli Lilly and Company

Completed

Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder

Major Depressive Disorder

United States
Image Dermatology P.C.

Completed

Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo

Intertrigo

United States
University of Buenos Aires
Laboratorios Phoenix S.A.I.C.y F.

Completed

Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers (PHOE10903)

Healthy Volunteers
National Institute of Allergy and Infectious Diseases...

Completed

Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

Influenza

United States
Ferring Pharmaceuticals

Withdrawn

Open-Label, Randomised Parallel-Group Study

Prostate Cancer
Pfizer

Completed

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Candidemia | Candidiasis

United States
Pfizer

Completed

This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis

Candidemia | Invasive Candidiasis

Panama, Brazil, Mexico, Chile, Colombia
Haukeland University Hospital
Norwegian Foundation for Health and Rehabilitation; Foundation to Promote Research...

Completed

Cobalamin Status in Young Children With Gastrointestinal Symptoms or Feeding Problems

Vitamin B 12 Deficiency

Norway
Graceway Pharmaceuticals, LLC

Completed

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Keratosis

United States

3

Subscribe